-
9721por Hamming, Ole J, Terczyńska-Dyla, Ewa, Vieyres, Gabrielle, Dijkman, Ronald, Jørgensen, Sanne E, Akhtar, Hashaam, Siupka, Piotr, Pietschmann, Thomas, Thiel, Volker, Hartmann, Rune“…The expression of IFNλ4 is correlated with both poor spontaneous clearance of hepatitis C virus (HCV) and poor response to treatment with type I interferon. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9722“…The second session dealt with the effector functions of anti-microbial antibodies, while the third was oriented toward anti-viral antibodies, with a special emphasis on antibodies directed against the human immunodeficiency and hepatitis C viruses. After a lecture by a speaker from the US Food and Drug Administration on antibody cocktails, the second day ended with a special session dedicated to discussions regarding the involvement of French biotechnology industries in the field. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9723“…Some are validated methods, such as the Fibrotest/ Fibrosure and transient elastography in Europe, and are gaining a growing role in routine clinical practice, especially in chronic hepatitis C. Large-scale validation is awaited in the setting of other chronic liver diseases. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9724por Franz, Cibele, Perez, Renata de Mello, Zalis, Mariano Gustavo, Zalona, Ana Carolina Jonard, Rocha, Pedro Túlio Monteiro de Castro e Abreu, Gonçalves, Renato Torres, Nabuco, Letícia Cancella, Villela-Nogueira, Cristiane Alves“…In this cross-sectional study, 207 hepatitis B surface antigen (HBsAg)-negative kidney transplant recipients were evaluated based on demographic and epidemiological data and on the levels of serological markers of hepatitis B virus (HBV) and hepatitis C virus infection and liver enzymes. Patients with HBV or human immunodeficiency virus infection were excluded. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9725“…Recently IFN-λ has entered clinical trials against hepatitis C Virus and IFN-λ is a promising future therapeutic, against different viruses replicating in responsive tissues, like that of the airway epithelia. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9726por Georgopoulou, Urania, Dimitriadis, Alexios, Foka, Pelagia, Karamichali, Eirini, Mamalaki, Avgi“…An estimated 30–40% of patients with chronic hepatitis C have elevated serum iron, transferrin saturation, and ferritin levels. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9727“…Rapidly mutating viruses, such as hepatitis C virus (HCV) and HIV, have adopted evolutionary strategies that allow escape from the host immune response via genomic mutations. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9728por Kazancioğlu, Rumeyza“…Experiencing acute kidney injury, a history of cardiovascular disease, hyperlipidemia, metabolic syndrome, hepatitis C virus, HIV infection, and malignancy are further risk factors. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9729por Mastroianni, Claudio M., Lichtner, Miriam, Mascia, Claudia, Zuccalà, Paola, Vullo, Vincenzo“…Chronic hepatitis C virus (HCV) infection is an important cause of morbidity and mortality in people coinfected with human immunodeficiency virus (HIV). …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9730por Torrecilla, Josune, Rodríguez-Gascón, Alicia, Solinís, María Ángeles, del Pozo-Rodríguez, Ana“…The efforts made to develop RNAi-based therapies have led to productive research in the field of infections in humans, such as hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), human cytomegalovirus (HCMV), herpetic keratitis, human papillomavirus, or influenza virus. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9731por Erzberger, Jan P., Stengel, Florian, Pellarin, Riccardo, Zhang, Suyang, Schaefer, Tanja, Aylett, Christopher H.S., Cimermančič, Peter, Boehringer, Daniel, Sali, Andrej, Aebersold, Ruedi, Ban, Nenad“…The structures of eIF3 components reported here also have implications for understanding the architecture of the mammalian 43S preinitiation complex and the complex of eIF3, 40S, and the hepatitis C internal ribosomal entry site RNA.…”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9732“…The study of hepatitis C virus (HCV) genotypes/subtypes, quasispecies and recombinants obtained by virus genome sequencing are important for epidemiological studies, to trace the source of infection, for development of new direct acting antivirals (DAAs) therapy and for understanding antiviral selection pressures. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9733“…We use protease PACE in the presence of danoprevir or asunaprevir, two hepatitis C virus (HCV) protease inhibitor drug candidates in clinical trials, to continuously evolve HCV protease variants that exhibit up to 30-fold drug resistance in only 1 to 3 days of PACE. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9734“…Recent evidence suggests that the Type III (λ) IFNs are intimately associated with the immune response to hepatitis C virus (HCV) infection. Genome-wide association studies have identified polymorphisms within the IFN-λ gene locus that correlate with response to IFNα-based antiviral therapy and with spontaneous clearance of HCV infection. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9735“…[Image: see text] Asunaprevir (ASV), an isoquinoline-based competitive inhibitor targeting the hepatitis C virus (HCV) NS3/4A protease, is very potent in vivo. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9736“…We describe the case of a patient with a history of hemoglobin SC disease and cirrhosis caused by hepatitis C presenting approximately 1 year after liver transplantation with an ASHC. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9737por Urraro, Teresa, Gragnani, Laura, Piluso, Alessia, Fabbrizzi, Alessio, Monti, Monica, Fognani, Elisa, Boldrini, Barbara, Ranieri, Jessica, Zignego, Anna Linda“…Mixed cryoglobulinemia (MC) is an autoimmune/B-cell lymphoproliferative disorder associated with Hepatitis C Virus (HCV) infection, manifesting as a systemic vasculitis. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9738“…Chronic hepatitis C virus (HCV) infection may eventually lead to progressive liver fibrosis and cirrhosis through a complex, multistep process involving hepatocyte death and regeneration. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9739“…Type 1 membranoproliferative glomerulonephritis (MPGN) is an immune complex-mediated disorder that has been associated with certain viral infections including hepatitis C, hepatitis B, hepatitis G, HIV and Hantavirus. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9740por Shibata, Chikako, Otsuka, Motoyuki, Kishikawa, Takahiro, Yoshikawa, Takeshi, Ohno, Motoko, Takata, Akemi, Koike, Kazuhiko“…The recent success of a human clinical trial using anti-miR-122 oligonucleotides against chronic hepatitis C virus has paved the way for this approach. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto